Evaluation of the protective efficacy of four newly identified surface proteins of Erysipelothrix rhusiopathiae.
Sign Up to like & getrecommendations! Published in 2018 at "Vaccine"
DOI: 10.1016/j.vaccine.2018.10.071
Abstract: Erysipelothrix rhusiopathiae is the causative agent of animal erysipelas and human erysipeloid. Bacterial surface proteins are promising vaccine candidates. We recently identified 3 E. rhusiopathiae surface proteins (GAPDH, HP0728, and HP1472) and characterized their roles… read more here.
Keywords: surface proteins; surface; gapdh; identified surface ... See more keywords